Cytek Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cytek Biosciences, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • Cytek Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 130M shares, a 4.26% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 130M -5.78M -4.26% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 132M -4.84M -3.55% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 131M -4.39M -3.24% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 131M -4.65M -3.44% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 136M +697K +0.52% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 136M +1.74M +1.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 136M +1.4M +1.04% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 135M +1.62M +1.21% Dec 31, 2022 10-K 2024-03-13
Q3 2022 135M +1.12M +0.84% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 135M +103M +319% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 134M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 134M +103M +328% Dec 31, 2021 10-K 2023-03-01
Q3 2021 134M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 32.1M Jun 30, 2021 10-Q 2021-09-03
Q4 2020 31.2M Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.